The goal of this program is to improve the management of localized renal cell carcinoma (RCC) with neoadjuvant and adjuvant therapy. After hearing and assimilating this program, the clinician will be better able to:Appraise the roles of various therapies for adjuvant and neoadjuvant treatment of renal cell carcinoma.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Urology
- Start Date: 2024-11-05 06:00:00
- End Date: 2024-11-05 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Jointly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest